Dr. Shook is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1975 4th St
San Francisco, CA 94143Phone+1 415-476-1000
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Johns Hopkins UniversityResidency, Pediatrics, 2004 - 2007- Johns Hopkins University School of MedicineClass of 2004
Purdue UniversityBS, Biology, Distinction; Honors Degree, 1996 - 2000
Certifications & Licensure
CA State Medical License 2020 - 2026
FL State Medical License 2015 - 2021
TN State Medical License 2007 - 2015- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Start of enrollment: 2008 Sep 01
- Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2009 Oct 01
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Start of enrollment: 2012 Aug 20
- Join now to see all
Publications & Presentations
PubMed
- 110 citationsLong-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle ce...Mari Hashitate Dallas, Brandon M. Triplett, David Shook, Christine Hartford, Ashok Srinivasan
Biology of Blood and Marrow Transplantation. 2013-05-01 - 44 citationsSelective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.Brandon M. Triplett, Brad Muller, Guolian Kang, Ying Li, Shane J Cross
Transplant Infectious Disease. 2018-02-01 - 34 citationsConsolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti...Aimee C Talleur, Brandon M. Triplett, Sara M. Federico, Ewelina Mamcarz, William E. Janssen
Biology of Blood and Marrow Transplantation. 2017-11-01
Journal Articles
- Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell DepletionBrandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease
Press Mentions
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
